Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $230 thousand versus the consensus estimate of $262.5 thousand.

For earnings history and earnings-related data on Inovio Pharma (INO) click here.